BiotechTube
GP Pharm

GP Pharm

Barcelona, Spain· Est.
gp-pharm.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

GP Pharm is a vertically integrated, privately held biopharmaceutical company with a 20+ year history, built on a core expertise in complex injectable drug delivery platforms. Its business model is diversified across internal R&D, contract development and manufacturing (CDMO), out-licensing partnerships (B2B), and direct marketing (B2C) of its own products in Spain. With regulatory approvals from major agencies (EMA, FDA, PMDA) for its manufacturing facilities, the company has established a significant international presence through strategic alliances while maintaining a strong domestic commercial footprint.

OncologyUrologyWomen's Health

Technology Platform

Specialized expertise in developing and manufacturing sustained-release injectable drug delivery systems, including microspheres, liposomes, and lipid nanoparticles (LNPs), for peptides, nucleic acids, and high-potency drugs.

Opportunities

High demand for lipid nanoparticle (LNP) expertise driven by the mRNA therapy revolution presents a major CDMO and partnership opportunity.
The growing market for complex injectables and sustained-release formulations in oncology and chronic diseases aligns perfectly with the company's core technological strengths.
Expansion of existing international licensing agreements into new geographic territories offers a lower-risk path to revenue growth.

Risk Factors

Revenue dependence on a limited number of key licensing and CDMO partners creates client concentration risk.
The highly regulated manufacturing environment poses ongoing compliance risk, where any facility issues could disrupt supply and damage reputation.
Intense competition in the CDMO and drug delivery space from larger, global players could pressure margins and client acquisition.

Competitive Landscape

GP Pharm competes with large, global CDMOs (e.g., Lonza, Catalent) and specialized drug delivery companies (e.g., Evonik, Pacira BioSciences) in the injectables space. Its differentiation lies in its deep, specific expertise in microspheres and LNPs, its fully integrated vertical model, and its regulatory-approved European manufacturing base. It competes on technological specialization and client service rather than scale.

More companies in Drug Delivery & Formulation →More companies in Spain →